Perform Another (Advanced) Search

1.  News: Cymbalta Reduces Pain in Fibromyalgia Trial (Clinical Trials Today)
...phase III trial of Cymbalta (duloxetine) for the treatment of fibromyalgia. Cymbalta is Lilly’s serotonin and norepinephrine reuptake inhibitor (SSNRI), approved in the U.S. for major depression and diabetic (peripheral neuropathic ...
View Page

2.  Newly Approved Drug Therapies (1012) Savella (milnacipran hydrochloride), Forest Laboratories,
...Approval Status: Approved January 2009 Treatment Area: fibromyalgia General Information Savella (milnacipran) is a selective serotonin and norepinephrine reuptake inhibitor. It affects the two neurotransmittersalmost equally (a 3:1 norepinephrine to serotonin balance ...
View Page

3.  CenterWatch: New Medical Therapies in Disease Category (195), Urinary Incontinence
...of a 12 week extension of their phase III study of Yentreve (duloxetine) , a dual serotonin/norepinephrine reuptake inhibitor for the treatment of stress urinary incontinence (SUI) in women. Post-hoc analysis ...
View Page

4.  Study Posting (2829) Trial #155112, Depression, San Antonio, TX
...who were identified as partial responders to an adequate course of treatment with a selective serotonin reuptake inhibitor (SSRI) (as defined by history). Inclusion Criteria: • Meet criteria for MDD as defined ...
...disorder (other than febrile seizures) • Are taking noradrenergic psychotropic medications, such as tricyclic antidepressants or serotonin norepinephrine reuptake inhibitors (SNRI) • Have received treatment with a MAOI within 14 days prior to ...
View Page

5.  Study Posting (1918) Trial #159850, Prostate Cancer, Savannah, GA
...See Disease Characteristics • More than 14 days since prior venlafaxine, monoamine oxidase inhibitor (MAOI), selective serotonin reuptake inhibitor (SSRI), or selective norepinephrine reuptake inhibitor (SNRI) • No concurrent chemotherapy, radiotherapy, or surgery • No concurrent estrogen, progestational agents, corticosteroids ...
View Page

6.  Study Posting (1918) Trial #159849, Hot Flash, Savannah, GA
...See Disease Characteristics • More than 14 days since prior venlafaxine, monoamine oxidase inhibitor (MAOI), selective serotonin reuptake inhibitor (SSRI), or selective norepinephrine reuptake inhibitor (SNRI) • No concurrent chemotherapy, radiotherapy, or surgery • No concurrent estrogen, progestational agents, corticosteroids ...
View Page